Roivant Sciences President & CIO Mayukh Sukhatme Surrenders Shares for Tax Withholding

Executive Summary

On October 20, 2026, Roivant Sciences Ltd. ($ROIV) filed a Form 4 on behalf of Mayukh Sukhatme, the company's President & Chief Investment Officer and Director. The report discloses a disposition of 19,976 common shares on October 16, 2026, at a price of $33.53 per share, totaling approximately $669,795.28.

Transaction Nature & Significance

• Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security).
• Context: According to the footnotes, this disposition was a net settlement to satisfy applicable tax withholding obligations tied to the vesting of performance restricted stock units (PSUs) granted in July 2024 following the achievement of performance and service conditions.
• Significance Level: Low. This is an administrative, non-discretionary transaction driven by statutory tax obligations rather than an open-market sale reflecting sentiment on the company's outlook.

Holdings Context

Following this transaction, Mayukh Sukhatme retains direct ownership of 18,563,884 Common Shares, indicating an overwhelming majority of his equity stake remains intact.